Cassava Sciences Inc

Ownership Transactions Reported by 13 Insiders

Symbol: SAVA on Nasdaq
Industry: Pharmaceutical Preparations
Location: 6801 N Capital Of Texas Highway, Building 1; Suite 300, Austin, Texas

There are no Buy or Sell transactions made by insiders since 9/12/2023

Cassava Sciences Inc executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Sanford Robertson	Director	$25.2M			May 16, 2024
Richard Barry	Director	$10.6M			May 9, 2024
Eric Schoen	Chief Financial Officer	$2.2M			Sep 6, 2024
James William Kupiec	Chief Medical Officer	$1.78M			Sep 6, 2024
Robert Christopher Cook	SVP & General Counsel	$1.69M			Sep 6, 2024
Remi Barbier	President & CEO, Director	$844K			May 20, 2024
Robert Z. Gussin	Director	$253K			May 9, 2024
Patrick J. Scannon	Director	$186K			May 9, 2024
Robert Eugene Anderson Jr	Director	$169K			May 9, 2024
Pierre Gravier	Director	$169K			May 9, 2024
Michael J. O. Donnell	Director	$169K			May 9, 2024
Claude Nicaise	Director	$169K			May 9, 2024
Nadav Friedmann	Chief Medical Officer, Director	$2.5K			Dec 31, 2022

Recent Insider Transactions by Companies or Individuals for Cassava Sciences Inc

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.